Research_updates - Articles - Page 3

Parent-Focused Therapy Outperforms Conjoint Therapy for Anorexia

September 1, 2016

Bret A. Moore, PsyD, ABPP

Few disorders frustrate clinicians as much as anorexia nervosa (AN). In the June 2015 issue of TCPR, we interviewed James Lock, who guided us through one of the few effective AN treatments, family-based therapy (FBT). In FBT, a family therapist works with the entire family to come up with a weight restoration plan for the patient.

Citalopram Safety Warning Has Serious Consequences for VA Patients

July 25, 2016

Bret A. Moore, PsyD, ABPP

...

N-acetylcysteine Shows Promise for Skin-Picking Disorder

July 25, 2016

Bret A. Moore, PsyD, ABPP

...

Atomoxetine Does Not Increase Risk of Suicide Compared to Stimulants

July 1, 2016

Bret A. Moore, PsyD, ABPP

Atomoxetine was not originally included in that rogue’s gallery of medications, but since the drug was originally developed as an antidepressant, the FDA later reviewed its safety data. A post-hoc meta-analysis of placebo-controlled trials revealed an increased risk of suicidal thinking, and so atomoxetine was also slapped with a black box warning.

RESEARCH UPDATE

Psychedelic Mushrooms May Help Treatment Resistant Depression

June 1, 2016

Bret A. Moore, PsyD, ABPP

Bret A. Moore, PsyD, ABPP

Board-Certified Clinical Psychologist, San Antonio, TX

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psilocybin, a naturally occurring and psychedelic compound of the Psilocybe species of mushrooms, has garnered the most attention.
Psilocybin is essentially a serotonin 2A agonist. Theoretically, this action should mediate depressive symptoms, but we don’t know for sure because no available antidepressants are direct agonists of this receptor. Researchers from the United Kingdom set out to see if this is indeed the case.

RESEARCH UPDATE

Good News for Smoking Cessation Drugs: Not as Scary as Once Thought

June 1, 2016

Bret A. Moore, PsyD, ABPP

Bret A. Moore, PsyD, ABPP

Board-Certified Clinical Psychologist, San Antonio, TX.

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Both varenicline (Chantix) and bupropion (Zyban) are effective anti-smoking agents, but over the years we’ve heard about potential neuropsychiatric side effects, especially related to varenicline. These include depression, suicidal thoughts, psychosis, and nightmares.

Second-Generation Antipsychotics Do Not Raise Risk of Major Malformations

May 13, 2016

Bret A. Moore, PsyD, ABPP

...

Meds for ADHD Not Working? Add CBT

May 1, 2016

Bret A. Moore, PsyD, ABPP. Board-Certified Clinical Psychologist, San Antonio, TX. Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Medication is an effective and necessary treatment for many adolescents struggling with ADHD. Unfortunately, even when patients and parents report significant relief from meds, symptoms persist, which can lead to ongoing problems at school, at home, and with peers. That’s why psychosocial interventions are an important part of any treatment plan for adolescents with ADHD.

Risperidone Leads to Serious Metabolic Problems in Autistic Children

May 1, 2016

Bret A. Moore, PsyD, ABPP. Board-Certified Clinical Psychologist, San Antonio, TX. Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The metabolic effects of atypical antipsychotics in children are well known, and carefully weighing the risk-benefit ratio of their use is a difficult ordeal for both parents and clinicians. The reality is that the use of these meds is necessary for some children, particularly those dealing with an autism spectrum disorder with serious behavioral problems.

RESEARCH UPDATE

When Physicians Become Addicted: How Well Do Treatment Programs Work?

May 1, 2016

Bret A. Moore, PsyD, ABPP

Bret A. Moore, PsyD, ABPP. Board-Certified Clinical Psychologist, San Antonio, TX.

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When physicians are diagnosed with opioid or other drug dependence, they are required to receive treatment from special physician health programs (PHP) if they want to keep their medical licenses. Unlike treatment programs for the general population, PHPs do not use opiate agonists, such as methadone or buprenorphine.